PHOSPHATE REGULATES THE STABILITY OF SKELETAL ALKALINE-PHOSPHATASE ACTIVITY IN HUMAN OSTEOSARCOMA (SAOS-2) CELLS WITHOUT EQUIVALENT EFFECTSON THE LEVEL OF SKELETAL ALKALINE-PHOSPHATASE IMMUNOREACTIVE PROTEIN

Authors
Citation
Jr. Farley, PHOSPHATE REGULATES THE STABILITY OF SKELETAL ALKALINE-PHOSPHATASE ACTIVITY IN HUMAN OSTEOSARCOMA (SAOS-2) CELLS WITHOUT EQUIVALENT EFFECTSON THE LEVEL OF SKELETAL ALKALINE-PHOSPHATASE IMMUNOREACTIVE PROTEIN, Calcified tissue international, 57(5), 1995, pp. 371-378
Citations number
33
Categorie Soggetti
Endocrynology & Metabolism
ISSN journal
0171967X
Volume
57
Issue
5
Year of publication
1995
Pages
371 - 378
Database
ISI
SICI code
0171-967X(1995)57:5<371:PRTSOS>2.0.ZU;2-F
Abstract
Inorganic phosphate (P-i) can regulate the level of skeletal alkaline phosphatase (ALP) activity in human osteoblast-like cells, but not by means of changes in transcription or release from the cell surface. Th e current studies were intended to determine whether (1) P-i affected the inactivation of ALP activity in human osteosarcoma (SaOS-2) cells; and (2) P-i-dependent changes in ALP-specific activity were associate d with equal, concomitant changes in the level of ALP immunoreactive p rotein. The results of these studies revealed that P-i increased the s tability of skeletal ALP activity without equivalent effects on the le vel of ALP immunoreactive protein. An increase in P-i (from 0 to 1.8 m mol/liter) caused a time-dependent increase in the amount of skeletal ALP activity in the SaOS-2 cells, without a parallel increase in the a mount of skeletal ALP immunoreactive protein, and a decrease in P-i (f rom 1.8 to 0 mmol/liter) caused a time-dependent decrease in the amoun t of ALP activity, without a significant decrease in the total cellula r content of ALP immunoreactive protein. Together, these observations suggest that P-i may alter the level of skeletal ALP activity in SaOS- 2 cells by inhibiting a process of irreversible inactivation that does not effect equal, concomitant changes in the level of skeletal ALP im munoreactive protein.